Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca

詳細情報 詳細情報について

• CRID

  1360018683014080384

• DOI

  10.1016/j.ijpharm.2021.121387

• ISSN

  03785173

• Web Site

  https://api.elsevier.com/content/article/PII:S0378517321011935?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0378517321011935?httpAccept=text/plain

• データソース種別

  • Crossref